OrthogenRx News

Visit us at LinkedIn and Twitter for the very latest news from OrthogenRx.

OrthogenRx at the American Medical Society for Sports Medicine Conference
We are excited to be exhibiting April 13-15.

OrthogenRx at AAOS 2019
This year OrthogenRx presented it’s anticipated new 3 injection hyaluronic acid regimen. TriVisc was the highlight at the booth.

NEW – OrthogenRx Launches TriVisc – 3 Injection Regimen
Clinically proven, safe and trusted products helps healthcare professionals make the difference in hyaluronic acids. This new addition to OrthogenRx provides more options for you to decide what’s best for each individual patient.

Over 45 Million Sold Worldwide – GenVisc 850 Hits a Milestone
The 5 injection regimen GenVisc 850 from OrthogenRx is now approved in 64 countries with over 45 million syringes distributed.